We have made our last update to the COVID-19 Treatment Guidelines! You can view the recent updates on our What's New page. The website will remain active until August 16, 2024. bit.ly/49qkRE6

View our Special Populations page for recommendations on managing #COVID19 in pregnant people, people who are immunocompromised, people with cancer, and other patient populations: bit.ly/3LyrwRL

This table contains drugs and products that have shown antiviral activity against #SARSCoV2 , including small-molecule antiviral drugs, #COVID19 convalescent plasma, and interferons:
bit.ly/3Njx8lj

Intravenous remdesivir is approved by the FDA for the treatment of #COVID19 in certain adult and pediatric patients. Information on the use of #remdesivir for the treatment of COVID-19 can be found here: bit.ly/43GalG8

Information on how #COVID19 impacts racial and ethnic minorities and other marginalized groups can be found on our Overview of COVID-19 page: bit.ly/3Pmpgik

Stay tuned for the last update to the #COVID19 Treatment Guidelines, which will be published this Thursday, Feb 29!

Read more about the future of the Guidelines on our What's New page: bit.ly/3VSWpVa

Information on the general management of nonhospitalized adults with acute #COVID19 can be found here: bit.ly/431iFzm

Looking for a certain section in the #COVID19 Treatment Guidelines? Our Table of Contents page can help: bit.ly/3TAVoiL

For guidance on managing #COVID19 in patients who are candidates, donors, or recipients of solid organ transplants, hematopoietic cell transplants, or cellular immunotherapy, follow the link:
bit.ly/3PfmklN

Follow the link for recommendations on the use of #COVID19 therapeutics in pregnant and lactating people: bit.ly/3MY24HZ

On the PDF copy of every section in the #COVID19 Treatment Guidelines, a QR code will direct you to the most recent version of that section on our website: bit.ly/3Sc0Lpy

Patients with #SARSCoV2 infection can experience a range of clinical manifestations, from no symptoms to critical illness. View our Clinical Spectrum of SARS-CoV-2 Infection page for more information:
bit.ly/41kMryw

These sections contain recommendations for managing children with #COVID19 or multisystem inflammatory syndrome in children (MIS-C): bit.ly/3bL6ZM3

Follow the link for recommendations on the use of ritonavir-boosted nirmatrelvir (Paxlovid) for the treatment of #COVID19 : bit.ly/3Ol4EIq

For an overview of the sections found in the #COVID19 Treatment Guidelines, view our Table of Contents page: bit.ly/3TAVoiL

The #COVID19 Treatment Guidelines will have one last update early this year. Read more about the future of the Guidelines and other updates on our What's New page: bit.ly/3VSWpVa

Treatment recommendations for patients who require conventional oxygen can be found on our Therapeutic Management of Hospitalized Adults With #COVID19 page: bit.ly/3BtOOVn

Recommendations for managing #COVID19 in pregnant people, people who are immunocompromised, and other special patient populations can be found here: bit.ly/3LyrwRL

View our Influenza and COVID-19 page for information on the diagnosis of influenza and #COVID19 when influenza viruses and #SARSCoV2 are cocirculating: bit.ly/3qpAoz5

Information on #COVID19 epidemiology, disparities in care, and #SARSCoV2 variants can be found on our Overview of COVID-19 page: bit.ly/3Pmpgik